Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Crinetics Pharmaceuticals (CRNX)
NASDAQ:CRNX
RESEARCH TOOLSreports
Holding CRNX?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | $ 399.00K | $ 640.00K | - | $ 346.00K |
| Gross Profit | - | $ 399.00K | $ 640.00K | - | $ 346.00K |
| EBIT | $ -76.83M | $ -74.06M | $ -73.53M | $ -62.66M | $ -58.98M |
| EBITDA | $ -76.06M | $ -69.45M | $ -73.06M | $ -62.40M | $ -58.70M |
| Net Income Common Stockholders | $ -76.83M | $ -74.04M | $ -66.93M | $ -60.10M | $ -57.46M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 862.67M | $ 862.95M | $ 900.96M | $ 558.55M | $ 554.65M |
| Total Assets | $ 937.37M | $ 935.53M | $ 978.15M | $ 635.35M | $ 641.54M |
| Total Debt | $ 52.54M | $ 53.32M | $ 52.50M | $ 51.73M | $ 52.17M |
| Net Debt | $ -810.13M | $ -809.63M | $ -848.46M | $ -506.83M | $ -502.48M |
| Total Liabilities | $ 104.39M | $ 104.77M | $ 103.22M | $ 96.25M | $ 93.79M |
| Stockholders Equity | $ 832.98M | $ 830.75M | $ 874.97M | $ 539.11M | $ 547.75M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -63.35M | $ -46.57M | $ -54.19M | $ -39.45M | $ -44.84M |
| Operating Cash Flow | $ -62.82M | $ -45.62M | $ -52.86M | $ -38.52M | $ -41.34M |
| Investing Cash Flow | $ 20.60M | $ -53.64M | $ 309.00K | $ -87.31M | $ -193.30M |
| Financing Cash Flow | $ 57.33M | $ 5.50M | $ 393.57M | $ 37.92M | $ 337.88M |